Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results

scPharmaceuticals Inc. (SCPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update"
06/08/2023 4 Baylor-Henry Minnie (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 Abraham William Tober (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 Hudson Frederick M. (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 Bonstein Sara (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 Khattar Jack A. (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 4 SCHAEFFER LEONARD D (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/07/2023 8-K Other Events  Interactive Data
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update"
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/22/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2023 10-K Annual Report for the period ended December 31, 2022
03/22/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update"
03/13/2023 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.1% stake in SCPHARMACEUTICALS INC.
03/10/2023 8-K Other Events  Interactive Data
02/27/2023 SC 13G Cowen Financial Products LLC reports a 7.1% stake in scPHarmaceuticals Inc.
02/14/2023 SC 13G/A 5AM Ventures IV, L.P. reports a 8% stake in scPharmaceuticals Inc.
02/14/2023 SC 13G ARMISTICE CAPITAL, LLC reports a 6.3% stake in SCPHARMACEUTICALS INC.
01/23/2023 4 Tucker John H (President and CEO) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 66,665 shares @ $6.14, valued at $409.3k
Granted 100,000 options to buy @ $6.14, valued at $614k
01/23/2023 4 Nokes Rachael (See Remarks) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Paid exercise price by delivering 1,981 shares @ $10.09, valued at $20k
Paid exercise price by delivering 1,976 shares @ $7.27, valued at $14.4k
Granted 11,700 shares @ $6.14, valued at $71.8k
Granted 17,550 options to buy @ $6.14, valued at $107.8k
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 8-K Quarterly results
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/25/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/23/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/23/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy